TARIS Biomedical Inc.
This article was originally published in Start Up
Executive Summary"Treat diseases locally" is a mantra espoused by a growing number of companies but few as yet have actually mustered the means to do so. TARIS Biomedical believes it has what it takes to become a pioneer of minimally invasive drug delivery devices. Its first product offering will be a pretzel-shaped device the size of a paper clip that will release medication inside the bladder, initially as a treatment for interstitial cystitis.
You may also be interested in...
As academic labs fill gaps in discovery work once performed by biopharma companies, Roche is confident that a U.S. consortium of academic drug-discovery units will lead to broader partnerships between industry and academia and within the academy itself. Plus, MedImmune acquires ADC specialist Spirogen and other deals from the past week.